Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Davis Stephen
Relationship:   Director
City:   Branford
State:   CT
   
Insider Summary:
  
   
Companies Owned :   5    
Direct Shares   344,117    

Indirect Shares

   0      
Direct Value   $2,513,419    

Indirect Value

   $0      
Total Shares   344,117      
Total Value   $2,513,419      


Heron Therapeutics Inc $156,096 Acadia Pharmaceuticals Inc $2,347,093 Bellicum Pharmaceuticals, Inc $10,230 Heron Therapeutics Inc $156,096 Acadia Pharmaceuticals Inc $2,347,093 Bellicum Pharmaceuticals, Inc $10,230
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    16    

     Stock price went up :
    0   
    7    
     Stock price went down :
    0   
    9    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
 -96.4%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Heron Therapeutics Inc HRTX Director 2022-12-16 52,032 2010-02-17 0    Premium*  
            Ardea Biosciences Inc RDEA EVP & COO 2012-06-19 0 2010-04-06 0    Premium*  
            Furiex Pharmaceuticals, Inc. FURX Director 2014-07-02 0 2013-05-24 0    Premium*  
            Acadia Pharmaceuticals Inc ACAD 2024-05-02 155,231 2019-10-09 0    Premium*  
            Bellicum Pharmaceuticals, Inc BLCM Director 2023-01-03 136,854 2022-01-04 0    Premium*  
* Premium Members only  

Records found :    95         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 4
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
ACAD Acadia Pharmaceuticals In... CEO   •       •      –    2019-10-09 4 OE $19.65 $585,413 D/D 29,792 29,792 0 -
ACAD Acadia Pharmaceuticals In... CEO   •       •      –    2019-10-09 4 AS $40.00 $1,191,710 D/D (29,792) 0 0 -
ACAD Acadia Pharmaceuticals In... CEO   •       •      –    2019-10-10 4 OE $19.65 $2,362,087 D/D 120,208 120,208 0 -
ACAD Acadia Pharmaceuticals In... CEO   •       •      –    2019-10-10 4 AS $40.19 $4,831,039 D/D (120,208) 0 0 -
ACAD Acadia Pharmaceuticals In... CEO   •       •      –    2019-10-15 4 S $39.65 $118,276 D/D (2,983) 2,954 0 -
ACAD Acadia Pharmaceuticals In... CEO   •       •      –    2019-10-15 4 OE $0.00 $0 D/D 5,937 5,937 0 -
ACAD Acadia Pharmaceuticals In... CEO   •       •      –    2019-12-05 4 OE $19.65 $2,947,500 D/D 150,000 152,954 0 -
ACAD Acadia Pharmaceuticals In... CEO   •       •      –    2019-12-05 4 AS $51.32 $7,851,300 D/D (150,000) 2,954 0 -
ACAD Acadia Pharmaceuticals In... CEO   •       •      –    2020-04-29 4 OE $0.00 $0 D/D 15,625 18,579 0 -
ACAD Acadia Pharmaceuticals In... CEO   •       •      –    2020-04-30 4 S $49.21 $333,152 D/D (6,770) 11,809 0 %
ACAD Acadia Pharmaceuticals In... CEO   •       •      –    2020-05-13 4 AS $45.12 $5,165,587 D/D (111,458) 11,809 0 %
ACAD Acadia Pharmaceuticals In... CEO   •       •      –    2020-05-13 4 OE $19.65 $2,190,150 D/D 111,458 123,267 0 -
ACAD Acadia Pharmaceuticals In... CEO   •       •      –    2020-05-14 4 AS $45.01 $4,039,105 D/D (88,542) 11,809 0 %
ACAD Acadia Pharmaceuticals In... CEO   •       •      –    2020-05-14 4 OE $19.65 $1,739,850 D/D 88,542 100,351 0 -
ACAD Acadia Pharmaceuticals In... CEO   •       •      –    2020-10-15 4 OE $0.00 $0 D/D 5,937 17,746 0 -
ACAD Acadia Pharmaceuticals In... CEO   •       •      –    2020-10-16 4 S $42.56 $125,978 D/D (2,960) 14,786 0 %
ACAD Acadia Pharmaceuticals In... CEO   •       •      –    2021-01-06 4 OE $0.00 $0 D/D 9,527 27,966 0 -
ACAD Acadia Pharmaceuticals In... CEO   •       •      –    2021-01-06 4 S $53.34 $185,837 D/D (3,484) 24,482 0 %
ACAD Acadia Pharmaceuticals In... CEO   •       •      –    2021-02-04 4 S $50.61 $718,409 D/D (14,195) 28,900 0 %
ACAD Acadia Pharmaceuticals In... CEO   •       •      –    2021-02-04 4 A $0.00 $0 D/D 31,250 43,059 0 -
ACAD Acadia Pharmaceuticals In... CEO   •       •      –    2021-04-29 4 OE $0.00 $0 D/D 15,625 57,162 0 -
ACAD Acadia Pharmaceuticals In... CEO   •       •      –    2021-04-30 4 S $20.33 $159,591 D/D (7,850) 49,312 0 %
ACAD Acadia Pharmaceuticals In... CEO   •       •      –    2021-10-15 4 OE $0.00 $0 D/D 5,938 55,869 0 -
ACAD Acadia Pharmaceuticals In... CEO   •       •      –    2021-10-18 4 S $17.41 $51,586 D/D (2,963) 52,906 0 %
ACAD Acadia Pharmaceuticals In... CEO   •       •      –    2022-01-06 4 OE $0.00 $0 D/D 9,527 62,434 0 -
  95  Records found
  1  2   3   4      
  Page 1 of 4  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us